Aligos Therapeutics logo
Aligos Therapeutics
ALGS | NASDAQ
Chart Builder DCF Calculator
$1.66
-$0.44 (-20.95%)
At close: Nov 16, 2026, 4:00 PM ET
$1.67
+$0.01 (+0.60%)
After-hours: Nov 16, 2026, 7:31 PM ET

Aligos Therapeutics Statistics

Key statistics explained

Market Data

$17.37M
$-1.83M
2.42
136.63K
10.46M
0.89%
21.98%
NASDAQ
US01626L2043

Price Performance

-65.8%
-74.8%
-69.0%
-82.2%
-76.3%
-90.3%
-99.6%
-65.8%
-75.1%
-65.2%
-57.3%

Valuation

-0.26
N/A
0.00
0.01
0.56
3.20
1.54
-0.25
-0.23
-0.25
-0.06
0.04
0.03
0.03
-382.5%
-395.4%
-426.6%

Financial Health

$19.19M
$11.9M
$31.09M
$47.19M
1.77
1.77
1.05
-0.19
-0.17
-5.75
0.00
-21.91
2

Margins & Profitability

99.2%
-235.6%
-182.6%
-197.0%
-223.1%
-240.7%
16.1%
-7.9%

Returns

-140.5%
-206.3%
-251.6%
-262.9%
-140.5%

Historical Growth (CAGR)

23.4%
50.5%
N/A
-4.4%
-31.2%
N/A
10.6%
7.2%
N/A

Analyst Forecasts

Buy
1
5.4%
-28.7%
Mar 4, 2027
-$2.03
6.3%
$537.5K
218.1%

Fair Value Estimates

N/A
N/A
N/A
N/A
$20.00
1104.8%

Cash Flow

$-68.37M
$-68.66M
$-74.08M
-$6.56
-$6.54
-203.2%

Income Statement

$30.78M
$30.52M
$-72.52M
$-61.81M
$-66.29M
-$6.35
$375.33K
$-808.35K
82

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.